TY -的T1 -预防开发的影响ies on the COVID-2019 epidemic in Shenzhen, China JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00599-2020 VL - 55 IS - 5 SP - 2000599 AU - Yang, Kai AU - Wang, Lingwei AU - Li, Furong AU - Chen, Dandan AU - Li, Xi AU - Qiu, Chen AU - Chen, Rongchang Y1 - 2020/05/01 UR - //www.qdcxjkg.com/content/55/5/2000599.abstract N2 - Coronavirus disease 2019 (COVID-19) patients were first reported in Wuhan, in the Hubei province of China, in December 2019; the disease then spread to all provinces of China and >90 countries over the next 2 months [1–5]. By 7 March 2020, COVID-19 had infected >90 000 people and led to >3000 deaths [6]. There are ∼20 million people living in Shenzhen, China, of which the external population from the internal area of China, including Hubei province, account for a large proportion. The high population density, the significant proportion of the external population and the high levels of mobility may have increased the possibility of the COVID-19 outbreak [7, 8]. The first COVID-19 patient in Shenzhen was admitted on 9 January 2020, and 419 cases were confirmed by 7 March 2020, ranking Shenzhen the top city outside Wuhan. Most of these patients were imported cases from the Hubei province, and there was no large-scale transmission or nosocomial infection in Shenzhen, until now.Early identification of imported cases, prevention of family clustering transmission, preventive measures in public areas and strict infection control procedures in hospitals were crucial for successful prevention of COVID-19 in Shenzhen, China https://bit.ly/2UDb5JA ER -